From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.

In today’s interconnected world, the spread of pathogenic microorganisms poses a significant challenge to global public health, economic stability, and ...

Jason Kelly, chief executive of Ginkgo Bioworks, spent a surprising amount of time on an earnings call with analysts last ...

The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest ...

NorthX Biologics and Demeetra are collaborating to help biotech companies reach Investigational New Drug and clinical ...

Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

OKLAHOMA CITY (AP) — Nikola Topic made his NBA debut Thursday night for the Oklahoma City Thunder and scored his first points after undergoing treatment for testicular cancer. The Serbian guard was ...

OKC Thunder guard Nikola Topić is available to make his NBA debut against the Milwaukee Bucks. Topić missed his first season with a torn ACL and was later diagnosed with testicular cancer in October.

It has been a long journey for the Oklahoma City Thunder to get guard Nikola Topic. During the 2024 NBA Draft process, Topic was thought to be a top five prospect in that class. Though, just as the ...

Leaning on the scorer's table, a crowd of a couple of hundred sounded like thousands. For the first time since his testicular cancer diagnosis in Oct. 2025, Nikola Topic checked into a basketball game ...

Eli Lilly snaps up Watertown biotech in $2.4 billion deal Orna Therapeutics, which engineers immune cells inside the body, will fold into one of the world’s largest drugmakers.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.